Business Context and Reporting Period
Company: Achieve Life Sciences, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: March 10, 2022
Reporting Period: Fourth quarter and full year ended December 31, 2021.
This filing serves as a notification that the company issued a press release on March 10, 2022, announcing its financial results for the specified period. The detailed results are contained in Exhibit 99.1.
Key Financial Metrics
The provided text is a cover sheet for the Form 8-K and does not contain specific numerical data regarding revenue, profit, cash flow, margins, debt, or liquidity. These figures are referenced as being included in the attached press release (Exhibit 99.1), which is not part of the input text.
Material Changes
No material changes or comparative financial data are detailed in this specific document. The filing solely references the announcement of results for the fourth quarter and year ended December 31, 2021.
Guidance, Outlook, and Risks
The text does not provide management commentary, forward-looking guidance, specific risk factors, or details on contingencies. It notes that the information in Item 2.02 and Exhibit 99.1 is furnished and shall not be deemed "filed" for purposes of Section 18 of the Exchange Act, nor incorporated by reference except as expressly set forth.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated March 10, 2022) for actual revenue, net income, and cash flow figures.
- Verify the specific details of the fourth quarter and full-year 2021 performance against prior periods.
- Check for any forward-looking statements or updated guidance within the attached press release.
- Confirm the status of the company's liquidity and debt obligations as detailed in the full financial report.